Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2012The Journal of Experimental MedicineOpen Access

Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSusan SchlennerRega Institute for Medical ResearchBWBenno WeigmannFriedrich-Alexander-Universität Erlangen-NürnbergQRQingguo RuanHenan University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schlenner et al. (2012) studied this question.

synapsesocial.com/papers/6aa019b4645fa8fa55ef7893https://doi.org/10.1084/jem.20112646
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells2005 · 987 citations
  2. 2Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis2000 · 355 citations
  3. 3Smad2 and Smad3 Are Redundantly Essential for the TGF-β–Mediated Regulation of Regulatory T Plasticity and Th1 Development2010 · 339 citations
  4. 4Notch1 and TGFβ1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells2008 · 189 citations
  5. 5DNA methylation controls Foxp3 gene expression2008 · 787 citations